India Drug Index

com.medengage.drugindex

Total installs
634.8K(634,817)
Rating
4.1(3 reviews)
Released
October 17, 2016
Last updated
September 4, 2024
Category
Medical
Developer
Neuroglia Health
Developer details
Name
Neuroglia Health
Website
unknown
Country
India
Address
393, Second Cross, Dollars Colony, JP Nagar 4th Phase, Bangalore
India Drug Index Header - AppWisp.com

Screenshots

India Drug Index Screenshot 1 - AppWisp.com
India Drug Index Screenshot 2 - AppWisp.com
India Drug Index Screenshot 3 - AppWisp.com
India Drug Index Screenshot 4 - AppWisp.com

Description

Description:
India Drug Index is a comprehensive information resource on drugs approved for use in India.
The app extensively covers over 3900+ drug entries, including the newly FDA-approved small molecules and 61,000+ generic brands marketed and prescribed all over India.

* Easy to use quick drug reference
* Free drug database provides complete information about the drugs and its pricing
* Helps in making better treatment and decision making
* Completely evidence-based with 500,000+ references
* Prepared by a team of 15 editors, which includes Top Physicians and Pharmacologists
* Based on the latest guidelines and PI

App Features:
1) You can search drug molecules for the complete prescribing and pricing information in detail. The information provided is incorporated from standard references or PI modules.
2) Enhanced with advanced searching ability to find individual or combination brands available in Indian markets. The latest pricing and company information is also listed side by side. You can find alternative or brand substitutes using our unique tool.
3) Updating. We update as per the new guidelines and policies on a regular day to day basis.
4) The drug database has the "full offline” option. You can choose to download the entire library offline for easy access. Once when you downloaded the app it does periodic updates in the background.

Update Policy:
Every day our internal search engine crawls 500+ publications to identify changes in dose, adverse effects and practice-insights. New molecules approved by FDA are added within 24 hours.

AppWisp - mobile app insights

AppWisp is a platform for mobile app insights. We provide a comprehensive overview of the mobile app ecosystem, including app store data, SDK usage, and more.

Free app store data

We provide free data on app store rankings, downloads and technology. Our data is updated daily and is available for both iOS and Android apps.

SDK insights

We provide insights into the SDKs used by mobile apps. Our data includes information on SDK usage, market share, and more.

API access

We offer an API that allows you to access our data programmatically. Our API is easy to use and provides access to all of our data.